Internal Medicine, Transplant Hepatology · Detroit, MI
NPI
1801027644
Since 2009
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2799 W Grand Blvd
Detroit, MI, 48202
Phone (313) 916-8899
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
442 services
Medicare patients, 2024
196
Average age 66
Drug cost, 2024
$5.5M
2,259 prescriptions
Company payments, 2025
$80K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed-Mohammed R Jafri was code 99214 (office e&m - established), 103 times for 82 patients. In total Syed-Mohammed R Jafri billed 442 services in 17 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 103 | 82 | $71.24 | $7,337 |
| 99232 Hospital E&M - Subsequent | Facility | 71 | 25 | $62.86 | $4,463 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 64 | 55 | $13.14 | $841 |
| 99214 Office E&M - Established | Office | 43 | 35 | $74.68 | $3,211 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 33 | $12.91 | $439 |
| 99222 Hospital E&M - Initial | Facility | 27 | 26 | $104.75 | $2,828 |
| 91200 Standard X-ray | Facility | 23 | 23 | $8.25 | $190 |
| 99204 Office E&M - New | Office | 17 | 17 | $111.73 | $1,899 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $137.84 | $1,654 |
By year: 2022 $23K for 426 services; 2023 $20K for 259 services; 2024 $27K for 442 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed-Mohammed R Jafri prescribed most often to Medicare patients was Ursodiol, with 309 prescriptions and refills. In total Syed-Mohammed R Jafri wrote 2,259 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 309 | 633 | 94 | $52K |
| Mycophenolate Mofetil Generic | 199 | 451 | 66 | $19K |
| Furosemide Generic | 141 | 310 | 55 | $759 |
| Xifaxan Rifaximin | 129 | 129 | 25 | $411K |
| Spironolactone Generic | 122 | 253 | 38 | $2,216 |
| Tacrolimus Generic | 112 | 257 | 53 | $23K |
| Prednisone Generic | 76 | 132 | 41 | $800 |
| Lactulose Generic | 67 | 91 | 25 | $1,366 |
| Gattex Teduglutide | 65 | 65 | Under 11 | $4.2M |
| Pantoprazole Sodium Generic | 63 | 114 | 21 | $682 |
| Loperamide Loperamide Hcl | 50 | 63 | 11 | $2,051 |
| Cyclosporine Modified Cyclosporine, Modified | 48 | 131 | 22 | $13K |
| Everolimus Generic | 40 | 60 | 13 | $108K |
| Omeprazole Generic | 39 | 108 | 19 | $704 |
| Entecavir Generic | 37 | 75 | Under 11 | $7,286 |
Brand drugs: - claims; generic drugs: 1,853 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed-Mohammed R Jafri $80K ($80K in general payments such as food, travel and fees) from 11 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 26 | $34K |
| Gilead Sciences, Inc. GILD | 25 | $20K |
| VectivBio AG | 4 | $12K |
| Abbvie Inc. ABBV | 13 | $11K |
| Intercept Pharmaceuticals, Inc. | 1 | $2,170 |
| Madrigal Pharmaceuticals MDGL | 1 | $71.39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29.37 |
| Dendreon Pharmaceuticals LLC | 1 | $29.14 |
| Novo Nordisk Inc NVO | 1 | $17.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.